ALDOB and metabolic dysfunction-associated steatotic liver disease: Similarly, research by Niu et al. and Martinez-Huenchullan et al. observed increased plasma ALDOB protein in both NAFLD patients and mice (Niu et al., 2019; Martinez-Huenchullan et al., 2021).